Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anette-G Ziegler

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Current Diabetes Reports|April 12, 2007
On the way to a diabetes cure? Improvement of glycemic control through islet transplantation with the use of a standardized common protocol: international trial of the Edmonton protocol for islet transplantationAnette- G Ziegler
Endocrinology and Metabolism Clinics of North America|August 21, 2010
Advances in the prediction and natural history of type 1 diabetesEzio Bonifacio, Anette G Ziegler
Current Diabetes Reports|August 13, 2010
Loss and preservation of beta-cell function: two treatment regimes targeting T or B lymphocytesAnette-G Ziegler, Markus Walter
Best Practice & Research. Clinical Endocrinology & Metabolism|April 14, 2005
Diabetes-related antibodies in euglycemic subjectsPeter Achenbach, Anette-G Ziegler
Nature Reviews. Endocrinology|December 1, 2020
Shortening the paths to type 1 diabetes mellitus preventionAnette-G Ziegler, Ezio Bonifacio
The American Journal of Clinical Nutrition|June 3, 2011
Early determinants of type 1 diabetes: experience from the BABYDIAB and BABYDIET studiesSandra Hummel, Anette G Ziegler
Immunity|April 24, 2010
Prediction and pathogenesis in type 1 diabetesAnette-G Ziegler, Gerald T Nepom
Cold Spring Harbor Perspectives in Medicine|August 22, 2012
Clinical immunologic interventions for the treatment of type 1 diabetesLucienne Chatenoud, Katharina Warncke, Anette-G Ziegler
Current Diabetes Reports|May 1, 2008
Inflammation at the islets of langerhans and its role for the pathogenesis of type 2 diabetesAnette-G Ziegler, Markus Walter, Heike Boerschmann
The Review of Diabetic Studies : RDS|May 12, 2007
Elimination of dietary gluten and development of type 1 diabetes in high risk subjectsMartin Füchtenbusch, Anette-G Ziegler, Michael Hummel
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Current Diabetes Reports|April 12, 2007
On the way to a diabetes cure? Improvement of glycemic control through islet transplantation with the use of a standardized common protocol: international trial of the Edmonton protocol for islet transplantationAnette- G Ziegler
Endocrinology and Metabolism Clinics of North America|August 21, 2010
Advances in the prediction and natural history of type 1 diabetesEzio Bonifacio, Anette G Ziegler
Current Diabetes Reports|August 13, 2010
Loss and preservation of beta-cell function: two treatment regimes targeting T or B lymphocytesAnette-G Ziegler, Markus Walter
Best Practice & Research. Clinical Endocrinology & Metabolism|April 14, 2005
Diabetes-related antibodies in euglycemic subjectsPeter Achenbach, Anette-G Ziegler
Nature Reviews. Endocrinology|December 1, 2020
Shortening the paths to type 1 diabetes mellitus preventionAnette-G Ziegler, Ezio Bonifacio
The American Journal of Clinical Nutrition|June 3, 2011
Early determinants of type 1 diabetes: experience from the BABYDIAB and BABYDIET studiesSandra Hummel, Anette G Ziegler
Immunity|April 24, 2010
Prediction and pathogenesis in type 1 diabetesAnette-G Ziegler, Gerald T Nepom
Cold Spring Harbor Perspectives in Medicine|August 22, 2012
Clinical immunologic interventions for the treatment of type 1 diabetesLucienne Chatenoud, Katharina Warncke, Anette-G Ziegler
Current Diabetes Reports|May 1, 2008
Inflammation at the islets of langerhans and its role for the pathogenesis of type 2 diabetesAnette-G Ziegler, Markus Walter, Heike Boerschmann
The Review of Diabetic Studies : RDS|May 12, 2007
Elimination of dietary gluten and development of type 1 diabetes in high risk subjectsMartin Füchtenbusch, Anette-G Ziegler, Michael Hummel
Pageof 21